Beneficial effect of diazoxide in obese hyperinsulinemic adults

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 1911-1915

  Alemzadeh, Ramin ^a,c   Langley, Gina ^a   Upchurch, Lori ^a   Smith, Pam ^a   Slonim, Alfred E ^b  

^a UNIVERSITY OF TENNESSEE GRADUATE SCHOOL OF MEDICINE   (United States)

^b School of Medicine   (United States)

^c UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; DIAZOXIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; ISOPHANE INSULIN; PLACEBO;

ADULT; ARTICLE; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DYSPEPSIA; EDEMA; FEMALE; GLUCOSE TOLERANCE; HEADACHE; HUMAN; HYPERINSULINEMIA; INSULIN RESISTANCE; INTRAVENOUS DRUG ADMINISTRATION; LOW CALORY DIET; MALE; OBESITY; ORAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; WEIGHT REDUCTION;

ADULT; BODY COMPOSITION; BODY MASS INDEX; BODY WEIGHT; DIAZOXIDE; DIET, REDUCING; ENERGY INTAKE; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERINSULINISM; INSULIN; MALE; OBESITY; PLACEBOS; WEIGHT LOSS;

ANIMALIA;

EID: 0031792482     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.1911     Document Type: Article

References (23)

1. Jeanrenaud B. 1978 Hyperinsulinemia in obesity syndromes: its metabolic consequences and possible etiology. Metabolism. 12:1881-1892.
2. Bray GA, York DA. 1979 Hypothalamic and genetic obesity in experimental animals. An autonomic endocrine hypothesis. Physiol Rev. 59:719-809.
3. Pénicaud L, Kinebanyan MF, Ferré P, et al. 1989 Development of VMH obesity: in vivo insulin secretion and tissue insulin sensitivity. Am J Physiol. 257:E255-E260.
4. Le Stunff C, Bougneres P. 1994 Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes. 43:696-702.
5. Rizza RA, Mandarino LJ, Genest J, Baker BA, Gerich JE. 1985 Production of insulin resistance by hyperinsulinemia in man. Diabetologia. 28:70-75.
6. Sigal RJ, El-Hashimy Mona, Martin BC, Soelner JS, Krolewski AS, Warram JH. 1997 Acute postchallenge hyperinsulinemia predicts weight gain. Diabetes. 46:1025-1029.
7. Rabinowitz D, Ziereler KL. 1962 Forearm metabolism in obesity and its response to intra-arterial insulin: characterization of insulin resistance and evidence for adaptation hyperinsulinism. J Clin Invest. 41:2173-2181.
8. Howard BV. 1984 The antilipolytic action of insulin in obese subjects with resistance to its glucoregulatroy action. J Clin Endocrinol Metab. 58:544-548.
9. Schade DS, Eaton RP. 1977 Dose response to insulin in man: differential effects on glucose and ketone body regulation. J Clin Endocrinol Metab. 44:1038-1047.
10. Alemzadeh R, Slonim AE, Zdanowicz MM, Maturo J. 1993 Modification of insulin resistance by diazoxide in obese Zucker rats. Endocrinology. 133:705-712.
11. Alemzadeh R, Jacobs W, Pitukcheewanont P. 1996 Antiobesity effect of diazoxide in obese Zucker rats. Metabolism. 45:334-341.
12. Yang YJ, Youn JH, Bergman R. 1987 Modified protocols improve insulin sensitivity estimation using the minimal model. Am J Physiol. 256:E413-E419.
13. Caro JF, Dolim LG, Walter JP, et al. 1989 Cellular alteration in liver, skeletal muscle, adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev. 5:665-689.
14. Polonsky KS, Given BD, Hirsch L, et al. 1988 Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest. 81:435-441.
15. Polonsky KS, Given BD, Van Cauter E. 1988 Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects. J Clin Invest. 81:442-448.
16. Ciaraldi TP, Kolterman OG, Olefsky JM. 1981 Mechanics of the post-receptor defect in insulin action in human obesity. J Clin Invest. 68:875-880.
17. +2 signaling and lipogenic activity in 3T3-L1 adipocytes. Obes Res 4: (Abstract 064, page 28S).
18. Zemel MB, Kim JH, Woychik RP, et al. 1995 Agouti regulation of intracellular calcium: role in insulin resistance of viable mice. Proc Natl Acad Sci USA. 92:4733-4737.
19. Jones BH, Kim JH, Zemel MB, et al. 1996 Up-regulation of adipocyte metabolism by agouti protein: possible paracrine actions in yellow mouse obesity. Am J Physiol. 33:E192-E196.
20. Kim JH, Mynatt RL, Moore JW, Woychik R, Moustaid N, Zemel MB. 1996 The effects of calcium channel blockade on agouti-induced obesity. FASEB J 10:1646-1652.
21. Weintraub M, Hasday JD, Mushlin AI, Lockwood DH. 1984 A double-blind clinical trial in weight control: use of fenfluramine and phentermine alone and combination. Arch Intern Med. 144:1143-1148.
22. Abenhain L, Monde Y, Brenot F, et al. 1996 Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 335:609-616.
23. Connolly HM, Crary JL, McGoon MD, et al. 1997 Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med. 337:581-588.